Pain Management Therapeutics Market Size, Share Global Analysis Report, , 2021 – 2026

Industry Insights

According to the report published by the Facts & Factors, global demand for the pain management therapeutics market was estimated at approximately USD 72,065.3 Million in 2020 and is expected to generate revenue of around USD 90,501.8 Million by the end of 2026, growing at a CAGR of around 4.8% between 2021 and 2026.

Market Overview

Pain is referred to disturbing sensory and emotional sensation resultant from tissue damage or disease. Many diseases cause discomforts like multiple sclerosis, chronic arthritis, cancer, stomach ulcer, osteoarthritis, fibromyalgia, and diabetic neuropathy. In addition, the length of pain ranges from acute pain intended for the short term to chronic pain intended for the long term. The acute pain can be mild and lasts for merely a moment, or sometimes weeks or months. Chronic pain is caused due to nerve damage or even injury, aged bone, and joint conditions. A variety of drugs are used for managing pain, which results from inflammation in response to tissue damage, chemical agents/pathogens (nociceptive pain), or nerve damage (neuropathic pain).

Industry Growth Factor

The increasing geriatric population is the key factor driving the market expansion of the global market because aged people are most prone to suffer from joint pain and other chronic disorders. In addition, the growing occurrence of chronic diseases like cancer, osteoarthritis, and diabetic neuropathy is fuelling the growth of the global pain management therapeutics market. Moreover, the mounting healthcare costs, different government initiatives, and the rising number of surgical procedures are other factors likely to stimulate the market development during the forecast period.

However, the patent expiration of prescription pain medication drugs, the drug exploitation, and the accessibility of substitutes like pain relief devices can slow down the market growth in the coming years. Besides, the rise in availability of a huge number of approved drugs for pain management treatment at retail pharmacies will create lucrative opportunities for the pain management therapeutics market in the near future.

Segmentation Analysis

The global pain management therapeutics market can be segmented into drug class, indication, pain type, and distribution channel. Based on the drug class, the global pain management therapeutics market can be classified into anesthetics, anticonvulsants, NSAIDs, anti-migraine drugs, opioids, antidepressant drugs, non-narcotics, and analgesics. In terms of indication, the global pain management therapeutics market can be divided into cancer pain, arthritic pain, acute appendicitis, neuropathic pain, chronic pain, post-operative pain, fibromyalgia, migraine, bone fracture, muscle sprain/strain, and others.

On the basis of type of pain, the global pain management therapeutics market can be bifurcated into chronic pain and acute pain. Based on the distribution channel, the global pain management therapeutics market can be segmented into hospital pharmacies, retail pharmacies, and online pharmacies.

Report Scope

Regional Analysis

In terms of revenue, North America is accounted for the majority of the market share in the global pain management therapeutics market. The increase in the prevalence of cancer and diabetes along with the increase in the number of approved pain management drugs, the increase in the geriatric population, and the rise in the number of clinical trials for the expansion of these products for numerous disorders are some factors that are likely to contribute significantly to the regional market upsurge.

Asia-Pacific is expected to witness a maximum growth rate in the forthcoming years due to key factors such as the increase in healthcare costs, the presence of large poop patients, and the growing awareness associated with pain management, mainly in rapidly rising countries such as China and India.

Competitive Players

• Novartis AG
• Johnson & Johnson Services Inc.
• WEX Pharmaceuticals
• Abbott Laboratories
• Zynerba Pharmaceuticals
• Bristol-Myers Squibb Company
• Endo Health Solutions Inc.
• Sanofi S.A
• Boehringer Ingelheim
• GlaxoSmithKline plc
• Sorrento Therapeutics
• Eli Lilly and Company
• Valeant Pharmaceuticals International Inc.
• Purdue Pharma L.P.
• Teva Pharmaceutical Industries Ltd
• Merck & Co. Inc.
• Baxter International Inc.
• Allergen Inc.
• Mylan NV
• Pfizer Inc

Furthermore, various companies in the market are concentrating on attaining approval from the FDA by escalating their product portfolio to get a benefit in the recent market outlook. Also, the increase in collaborations between researchers and drug developers is anticipated to boost the global pain management therapeutics market in the upcoming years.

By Drug Class Segment Analysis

• Anesthetics
• Anticonvulsant
• NSAIDs
• Anti-Migraine Drugs
• Opioids
• Antidepressant Drugs
• Non-Narcotics
• Analgesics

By Indication Segment Analysis

• Cancer Pain
• Arthritic Pain
• Acute Appendicitis
• Neuropathic Pain
• Chronic Pain
• Post-Operative Pain
• Fibromyalgia
• Migraine
• Bone Fracture
• Muscle Sprain/Strain
• Other Indications

By Pain Type Segment Analysis

• Chronic Pain
• Acute Pain

By Distribution Channel Segment Analysis

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Regional Segment Analysis

• North America
  • U.S.
  • Canada
• Europe
  • U.K.
  • France
  • Germany
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• The Middle East and Africa
  • GCC Countries
  • South Africa
  • Rest of Middle East Africa